The Biden Administration's Push to Lower Drug Prices Through March-In Rights

Daniel G Aaron; J Jonas Anderson

doi:10.1001/jama.2024.12327

The Biden Administration's Push to Lower Drug Prices Through March-In Rights

JAMA. 2024 Aug 13;332(6):449-450. doi: 10.1001/jama.2024.12327.

Authors

Daniel G Aaron¹, J Jonas Anderson¹

Affiliation

¹ S.J. Quinney College of Law at The University of Utah, Salt Lake City.

PMID: 39008321
DOI: 10.1001/jama.2024.12327

No abstract available

Plain language summary

This Viewpoint explores a 2023 Biden administration proposal for US agencies to use their march-in rights and the impact this proposed framework could have on drug prices.

Publication types

Editorial

MeSH terms

Drug Costs* / legislation & jurisprudence
Drug Industry* / economics
Drug Industry* / legislation & jurisprudence
Federal Government
Humans
United States